{"raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nFor the compound of formula (4) the dissociation constant Kd for BRD4- BD1 was determined to be 0.3 \u03bc\u039c whereas the respective value for the compound of formula (3) with R5 being methyl was 20 \u03bc\u039c.\nThe concentration required to reduce the population of a culture of HL-60 cells by 50% (GI50) was 14 \u03bc\u039c for the compound of formula (4)."}
{"final_json": [{"molecule_name": "compound of formula (4)", "protein_target_name": "BRD4-BD1", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "Kd", "value": "0.3", "unit": "\u03bc\u039c"}, {"molecule_name": "compound of formula (3)", "protein_target_name": "BRD4-BD1", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "Kd", "value": "20", "unit": "\u03bc\u039c"}, {"molecule_name": "compound of formula (4)", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "GI50", "value": "14", "unit": "\u03bc\u039c"}]}
{"raw_mentions": "Here are the extracted sentences:\n\nThe reproducible value of the dissociation constant (Kd) of the compound of formula (4) in complex with BRD4-BD1 was shown to be 0.16 \u03bc\u039c (n = 2) in terms of this assay, in close agreement with the 0.3 \u03bc\u039c observed by ITC measurements (n = 5).\nIn the BROMOscan\u2122 assay, the compound of formula (4) was found to bind specifically to the BET bromodomain family, with Kd values between 1 .5 and 3.5 \u03bc\u039c.\nThe compound of formula (4) showed -3.5 \u03bc\u039c binding affinity to these two other BRDs.\nIn the case of CREBBP, the compound ischemin (Kd = 19 \u03bc\u039c) was found to inhibit its association with p53, further blocking apoptosis in cardiomyocytes.\nThe compound of formula (4) exhibited a GI50 value between 5 and 20 \u03bc\u039c in HL-60 cells and no antiproliferative activity against HeLa at a high concentration of 50 \u03bc\u039c.\nPart A shows the growth inhibition (Gl, %) observed after incubation of each cell line with the compound of formula (4) at a concentration of 10 \u03bc\u039c."}
{"final_json": [{"molecule_name": "compound of formula (4)", "protein_target_name": "BRD4-BD1", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "Kd", "value": "0.16", "unit": "\u03bc\u039c"}, {"molecule_name": "compound of formula (4)", "protein_target_name": "BET bromodomain family", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "Kd", "value": "1.5-3.5", "unit": "\u03bc\u039c"}, {"molecule_name": "compound of formula (4)", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": null, "value": "-3.5", "unit": "\u03bc\u039c"}, {"molecule_name": "ischemin", "protein_target_name": "CREBBP", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "Kd", "value": "19", "unit": "\u03bc\u039c"}, {"molecule_name": "compound of formula (4)", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "GI50", "value": "5-20", "unit": "\u03bc\u039c"}, {"molecule_name": "compound of formula (4)", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "GI50", "value": ">50", "unit": "\u03bc\u039c"}, {"molecule_name": "compound of formula (4)", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "Gl", "value": null, "unit": "%"}]}
{"raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n\nThe compound of formula (3) with R5 being methyl , as a representative of the new 4-acyl pyrrole BET family inhibitors, displayed the highest ligand efficiency indexes among the studied compounds, with an LE value of 0.43 and LLE of 3.7 kcal-mol^-1-heavy atom^-1.\nThe value of LD50 of the substance for mice (male and female) is higher than 2000 mg/kg of body weight. \npKd, quantitative estimate of drug-likeness (QED), ligand efficiency (LE, calculated as 1 ,37(pKd/number of heavy atoms), kcal-moM-heavy atom^-1), and ligand-lipophilicity efficiency (LLE, calculated as pKd - dogPo/w) are shown"}
{"final_json": [{"molecule_name": "compound of formula (3) with R5 being methyl", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "LE", "value": "0.43", "unit": null}, {"molecule_name": "compound of formula (3) with R5 being methyl", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "LLE", "value": "3.7", "unit": "kcal-mol^-1-heavy atom^-1"}, {"molecule_name": null, "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "LD50", "value": ">2000", "unit": "mg/kg"}, {"molecule_name": null, "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "pKd", "value": null, "unit": null}]}
